{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Chronic Use of Benzodiazepine in Older Adults and Its Relationship with Dementia: A Systematic Review and Meta-Analysis
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
Method of Participation in the Learning Process/Evaluation Method Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form. Getting the Most out of the Activity As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed. While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.Purpose of Activity
The purpose of this learning activity is to provide information regarding current research on chronic use of benzodiazepines (BZ) for managing conditions--such as anxiety, depression, and sleep disorders, and other chronic diseases--and its potential link to dementia risk.Learning Objectives
After completing this continuing education activity you will be able to:
Explain current understanding of the relationship between chronic benzodiazepine use and dementia.
Disclosures
All authors, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity.
Disclaimer: Clinicians should ensure that all diagnostic and therapeutic modalities are prescribed and used appropriately, based on accepted standards of care. Use of any drugs, devices, and imaging techniques should be guided by approved labeling/full prescribing information, best available evidence, and professional judgment. Faculty have been instructed that their content should be fair balanced and based on best available evidence. The information presented in this activity is the responsibility of the faculty and does not reflect the opinions of the provider.
Price:
$12.95
Credits:
- ACCME 1.0 CME
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Physician
Test Code: HRP0125
Published: Jan/Feb 2025
Expires: 1/31/2027
Sources:
Harvard Review of Psychiatry
Required Passing Score: 7/10 (70%)
Categories:
Psychiatric
Specialties:
Psychiatry